Fast-RSOM skin scan identifies early cardiovascular risk by imaging tiny blood vessels and functional changes before symptoms ...

In patients with type 2 diabetes and heart failure, those assigned oral semaglutide had reduced risk for heart failure events ...

We're excited to support a new $55m global research programme called VISIBLE from Wellcome Leap - jointly funded by Pivotal - ...

Those with preserved EF seemed to get more protection against HF events/CV death than those with reduced or unknown EF.

Heart disease remains the leading cause of death for women. Despite advancements in awareness and research, gaps remain in ...

In a new study that could have significant implications for future Alzheimer's treatment, researchers at the University of ...

Patients can speak more clearly. Swallowing improves. Facial symmetry is restored to a large extent. Most importantly, ...

Heart & Stroke has released a new report offering a clear picture of the growing risks to heart and brain health in Canada.

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

A new imaging technology called fast-RSOM lets researchers see the smallest blood vessels in the body without invasive procedures. It can detect early dysfunction in these vessels — a quiet warning ...

Supriya Chakraborty might have been studying insects in a lab had it not been for an immunology college instructor in India ...